Latest In Research

The good news is that treatment options for lung cancer patients are rapidly improving. In the last two years, more treatments have been approved by the United States Food and Drug Administration (FDA) for the treatment of lung cancer than had been approved in the prior ten years. New and life saving treatments, along with clinical trials, are happening rapidly and LCFA is committed to keeping you up to date on the latest, most hopeful and helpful, information.


What good is it to be able to cure cancer if we routinely fail to deliver that cure?

From MedScape 'How Could We Fail so Miserably?' Real-World Evidence Offers Sobering Reality We are doing an unconscionably poor job of delivering appropriate targeted therapies to our patients. That's the only conclusion I can draw, based o…


Artificial intelligence and cancer

From Fred Hutch News Service New study tests ability of natural language processing to search lung cancer patients’ records for treatable mutations When rural Minnesota music teacher Shelly Engfer-Triebenbach started getting winded while…


Know Your Genes: Testing for Genomic Mutations in Lung Cancer

From Cure Today Testing for genomic mutations in lung cancer helps pinpoint targeted therapies. Amanda Nerstad was 39 years old and a busy working mother of two young children when she learned she had metastatic lung cancer in 2016. She was…


Lung Cancer Stigma: Not Just the Patient’s Problem

From MedPage Today How healthcare professionals have an impact - for better or worse. A previous Reading Room article discussed the various forms of stigma that lung cancer patients experience, including internalized negative feelings of sh…


Could invigorating the immune system prevent lung cancer?

From Medical News Today Scientists have identified biological changes in apparently normal airway tissue that could potentially predict the development of lung cancer. The changes alter gene and cell activity in the immune system. A team fr…


Precision of Liquid Biopsy and Osimertinib Resistance

From Globe Newswire Biodesix® will release new data demonstrating the potential diagnostic utility of a blood-based test for patients with resistance to osimertinib, and on the precision of liquid biopsy in comparison to tissue biopsy. Two…


Current Open Clinical Trials

From UCLA Thoracic Oncology Translational Research Current and open clinical trials have been announced at UCLA Main Campus and various satellite centers. The trials include:  Clinical Trial: Relapsed or Refractory Small Cell Lung Cancer …


FDA approves new treatment for extensive-stage small cell lung cancer

From Combination Therapy for SCLC On March 18, 2019, the Food and Drug Administration approved atezolizumab (TECENTRIQ, Genentech Inc.) in combination with carboplatin and etoposide, for the first-line treatment of adult patients …


El Paso County Public Health advises people to test homes for radon

From COLORADO SPRINGS, Colo. (KKTV) January was National Radon Action Month Radon and Lung cancer: “Radon is a clear, odorless, colorless radioactive gas that seeps through the soil from the breakdown of uranium,” said Marla Luckey,…


Antibiotics or anti-inflammatory drugs may help combat lung cancer

from MIT News Bacteria promote lung tumor development, study suggests MIT cancer biologists have discovered a new mechanism that lung tumors exploit to promote their own survival: These tumors alter bacterial populations within the lung, pr…

Research is imperative to improve treatment and management of all diseases and that’s particularly true of lung cancer. It’s creation of new knowledge, it’s discovery. It’s how we learn how to improve management of symptoms, to improve survival. ~Dr. David Johnson